Research Progress on the Analysis of Anabolic Androgenic Steroids in Biological Samples Based on High Resolution Mass Spectrometry

doi:10.12116/j.issn.1004-5619.2024.340705

Abstract

Abstract:

Anabolic androgenic steroids （AASs） are a class of synthetic steroid hormones that mimic androgens, and they rank as the most widely abused doping agents worldwide. High resolution mass spectrometry （HRMS） has unique advantages in the detection of AASs due to its high resolution, high sensitivity, high selectivity and data traceability. HRMS can not only be used for the qualitative and quantitative analysis of AASs and their metabolites in different biological samples, effectively improving the ability to analyze complex samples and increasing the reliability of analytical results, but can also infer AASs metabolites and reveal metabolic pathways by combining in vitro and in vivo metabolic models. This paper reviews the research progress of HRMS in AASs analysis methods, in vitro and in vivo metabolism of AASs, and also explores its application prospects in the field of forensic science.

Key words: forensic medicine, toxicological analysis, high resolution mass spectrometry （HRMS）, anabolic androgenic steroid, doping agent, biological sample, metabolite, review

CLC Number:

Zhen-shuo GUO, Wen-jia DUAN, Yu LIU, Yi-ling TANG, Hui YAN. Research Progress on the Analysis of Anabolic Androgenic Steroids in Biological Samples Based on High Resolution Mass Spectrometry[J]. Journal of Forensic Medicine, 2024, 40(6): 533-541.

Figures/Tables 3

References 49

1	FANG H， TONG W， BRANHAM W S， et al. Study of 202 natural， synthetic， and environmental chemicals for binding to the androgen receptor[J]. Chem Res Toxicol，2003，16（10）：1338-1358. doi：10.1021/tx030011g .
2	PEREIRA DE JÉSUS-TRAN K， CÔTÉ P L， CANTIN L， et al. Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity[J]. Protein Sci，2006，15（5）：987-999. doi：10.1110/ps.051905906 .
3	CHOI P Y L， PARROTT A C， COWAN D. High-dose anabolic steroids in strength athletes： Effects upon hostility and aggression[J]. Hum Psychopharm Clin，1990，5（4）：349-356. doi：10.1002/hup.470050407 .
4	WU Z， MA A， XING L， et al. Development an automated and high-throughput analysis methods for detecting 64 anabolic androgenic steroids in urine using gas chromatography-mass spectrometry[J]. Talanta Open，2024，10：100362. doi：10.1016/j.talo.2024.100362 .
5	金陈飞，崔梦竹，梁红艳，等. 液相色谱-串联质谱法检测类固醇激素在CAH筛查中的应用进展[J].国际检验医学杂志，2021，42（7）：881-885，894. doi：10.3969/j.issn.1673-4130.2021.07.027 .
	JIN C F， CUI M Z， LIANG H Y， et al. Advances in the application of liquid chromatography-tandem mass spectrometry in the detection of steroid hormones in CAH screening[J]. Guoji Jianyan Yixue Zazhi，2021，42（7）：881-885，894.
6	MARCOS J， PASCUAL J A， DE LA TORRE X， et al. Fast screening of anabolic steroids and other banned doping substances in human urine by gas chromatography/tandem mass spectrometry[J]. J Mass Spectrom，2002，37（10）：1059-1073. doi：10.1002/jms.365 .
7	GEORGAKOPOULOS C G， VONAPARTI A， STAMOU M， et al. Preventive doping control analysis： Liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids[J]. Rapid Commun Mass Spectrom，2007，21（15）：2439-2446. doi：10.1002/rcm.3103 .
8	JEON B W， YOO H H， JEONG E S， et al. LC-ESI/MS/MS method for rapid screening and confirmation of 44 exogenous anabolic steroids in human urine[J]. Anal Bioanal Chem，2011，401（4）：1353-1363. doi：10.1007/s00216-011-5210-1 .
9	VAN POUCKE C， VAN DE VELDE M， VAN PETEGHEM C. Combination of liquid chromatography/tandem mass spectrometry and gas chromatography/mass spectrometry for the detection of 21 anabolic steroid residues in bovine urine[J]. J Mass Spectrom，2005，40（6）：731-738. doi：10.1002/jms.845 .
10	FABRESSE N， GRASSIN-DELYLE S， ETTING I， et al. Detection and quantification of 12 anabolic steroids and analogs in human whole blood and 20 in hair using LC-HRMS/MS： Application to real cases[J]. Int J Legal Med，2017，131（4）：989-999. doi：10.1007/s00414-017-1552-3 .
11	HINES J M， BANCOS I， BANCOS C， et al. High-resolution， accurate-mass （HRAM） mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders[J]. Clin Chem，2017，63（12）：1824-1835. doi：10.1373/clinchem.2017.271106 .
12	ABUSHAREEDA W， LYRIS E， KRAIEM S， et al. Gas chromatographic quadrupole time-of-flight full scan high resolution mass spectrometric screening of human urine in antidoping analysis[J]. J Chromatogr B Analyt Technol Biomed Life Sci，2017，1063：74-83. doi：10.1016/j.jchromb.2017.08.019 .
13	TUDELA E， DEVENTER K， GELDOF L， et al. Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chroma-tography-high resolution mass spectrometry[J]. Drug Test Anal，2015，7（2）：95-108. doi：10.1002/dta.1650 .
14	GÖSCHL L， GMEINER G， ENEV V， et al. Development and validation of a simple online-SPE method coupled to high-resolution mass spectrometry for the analysis of stanozolol-N-glucuronides in urine samples[J]. Drug Test Anal，2020，12（8）：1031-1040. doi：10.1002/dta.2805 .
15	HE G， WU Y， LU J. Doping control analysis of 13 steroids and structural-like analytes in human urine using Quadrupole-Orbitrap LC-MS/MS with parallel reaction monitoring （PRM） mode[J]. Steroids，2018，131：1-6. doi：10.1016/j.steroids.2017.12.011 .
16	JI Z， LIAO L， GE Y， et al. Screening anabolic androgenic steroids in human urine： An application of the state-of-the-art gas chromatography-Orbitrap high-resolution mass spectrometry[J]. Anal Bioanal Chem，2024，416（13）：3223-3237. doi：10.1007/s00216-024-05272-2 .
17	ELMONGY H， MASQUELIER M， ERICSSON M. Development and validation of a UHPLC-HRMS method for the simultaneous determination of the endogenous anabolic androgenic steroids in human serum[J]. J Chromatogr A，2020，1613：460686. doi：10.1016/j.chroma.2019.460686 .
18	LIU W， ZHANG L， FAN L， et al. An improved hollow fiber solvent-stir bar microextraction for the preconcentration of anabolic steroids in biological matrix with determination by gas chromatography-mass spectrometry[J]. J Chromatogr A，2012，1233：1-7. doi：10.1016/j.chroma.2012.01.064 .
19	KOSKIVUORI J， VOUTILAINEN R， UUSITALO L， et al. A quantitative ultra-performance liquid chromatography high-resolution mass spectrometry analysis of steroids from human scalp hair[J]. J Pharm Biomed Anal，2022，215：114768. doi：10.1016/j.jpba.2022.114768 .
20	KWOK K Y， CHOI T L S， KWOK W H， et al. Detection of anabolic and androgenic steroids and/or their esters in horse hair using ultra-high performance liquid chromatography-high resolution mass spectrometry[J]. J Chromatogr A，2017，1493：76-86. doi：10.1016/j.chroma.2017.03.007 .
21	GHEDDAR L， RAUL J S， KINTZ P. Testing for stanozolol， using UHPLC-MS-MS and confirmation by UHPLC-q-TOF-MS， in hair specimens collected from five different anatomical regions[J]. J Anal Toxicol，2020，44（8）：834-839. doi：10.1093/jat/bkaa023 .
22	LEVERNÆS M C S， SOLHEIM S A， BRODER-STAD L， et al. Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers[J]. Drug Test Anal，2024，16（12）：1510-1527. doi：10.1002/dta.3660 .
23	JING J， SHAN Y， LIU Z， et al. Automated online dried blood spot sample preparation and detection of anabolic steroid esters for sports drug testing[J]. Drug Test Anal，2022，14（6）：1040-1052. doi：10.1002/dta.3226 .
24	SOLHEIM S A， LEVERNAES M C S， MØRKE-BERG J， et al. Stability and detectability of testosterone esters in dried blood spots after intramuscular injections[J]. Drug Test Anal，2022，14（11/12）：1926-1937. doi：10.1002/dta.3030 .
25	KINTZ P， GHEDDAR L， AMELINE A， et al. Identification of S22 （ostarine） in human nails and hair using LC-HRMS. Application to two authentic cases[J]. Drug Test Anal，2020，12（10）：1508-1513. doi：10.1002/dta.2902 .
26	BREUER J， THOMAS A， DELAHAUT P， et al. Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry[J]. Anal Bioanal Chem，2023，415（4）：669-681. doi：10.1007/s00216-022-04456-y .
27	PÖHÖ P， SCHOLZ K， KÄRKKÄINEN N， et al. Analysis of steroids in urine by gas chromatography-capillary photoionization-tandem mass spectrometry[J]. J Chromatogr A，2019，1598：175-182. doi：10.1016/j.chroma.2019.03.061 .
28	GAUDL A， KRATZSCH J， BAE Y J， et al. Liquid chromatography quadrupole linear ion trap mass spectrometry for quantitative steroid hormone analysis in plasma， urine， saliva and hair[J]. J Chromatogr A，2016，1464：64-71. doi：10.1016/j.chroma. 2016.07.087 .
29	BAGLAI A， BLOKLAND M H， MOL H G J， et al. Enhancing detectability of anabolic-steroid residues in bovine urine by actively modulated online comprehensive two-dimensional liquid chromatography-high-resolution mass spectrometry[J]. Anal Chim Acta，2018，1013：87-97. doi：10.1016/j.aca.2017.12.043 .
30	POLET M， VAN GANSBEKE W， VAN EENOO P， et al. Efficient approach for the detection and identification of new androgenic metabolites by applying SRM GC-CI-MS/MS： A methandienone case study[J]. J Mass Spectrom，2016，51（7）：524-534. doi：10.1002/jms.3781 .
31	严慧，沈敏，向平，等. 毛发中合成类固醇兴奋剂分析的进展[J].中国司法鉴定，2006（6）：21-25. doi：10.3969/j.issn.1671-2072.2006.06.007 .
	YAN H， SHEN M， XIANG P， et al. Hair analysis of anabolic steroids in doping control[J]. Zhongguo Sifa Jianding，2006（6）：21-25.
32	严慧. 毛发中外源性蛋白同化雄性类固醇的检测及评价研究[D].上海：复旦大学，2008.
	YAN H. Detection and evaluation of exogenous anabolic androgenic steroids in hair[D]. Shanghai： Fudan University，2008.
33	THIEME D， ANIELSKI P. Doping， applications of hair analysis[M]// KINTZ P， SALOMONE A， VINCENTI M. Hair analysis in clinical and forensic toxicology. Amsterdam： Elsevier Inc.，2015：275-299. doi：10.1016/b978-0-12-801700-5.00010-8 .
34	KINTZ P. A new series of hair test results involving anabolic steroids[J]. Toxicol Anal Clin，2017，29（3）：320-324. doi：10.1016/j.toxac.2017.05.003 .
35	KINTZ P， GHEDDAR L， AMELINE A， et al. Complete post-mortem investigations in a death involving clenbuterol after long-term abuse[J]. J Anal Toxicol，2019，43（8）：660-665. doi：10.1093/jat/bkz058 .
36	SOLHEIM S A， RINGSTED T K， NORDSBORG N B， et al. No pain， just gain： Painless， easy， and fast dried blood spot collection from fingertip and upper arm in doping control[J]. Drug Test Anal，2021，13（10）：1783-1790. doi：10.1002/dta.3135 .
37	LUGINBÜHL M， GAUGLER S. The application of fully automated dried blood spot analysis for liquid chromatography-tandem mass spectrometry using the CAMAG DBS-MS 500 autosampler[J]. Clin Biochem，2020，82：33-39. doi：10.1016/j.clinbiochem.2020.02.007 .
38	何欣龙，梅宏成，王继芬，等. 人指甲中氢、氧稳定同位素在法医学领域的应用[J].人类学学报，2020，39（3）：483-494. doi：10.16359/j.cnki.cn11-1963/q.2020.0002 .
	HE X L， MEI H C， WANG J F， et al. Research and application on hydrogen and oxygen stable isotopes of human fingernails in forensic science[J]. Renleixue Xuebao，2020，39（3）：483-494.
39	THEVIS M， KUURANNE T， GEYER H. Annual banned-substance review： Analytical approaches in human sports drug testing 2019/2020[J]. Drug Test Anal，2021，13（1）：8-35. doi：10.1002/dta.2969 .
40	PIPER T， SCHÄNZER W， THEVIS M. Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry[J]. J Steroid Biochem Mol Biol，2016，162：80-91. doi：10.1016/j.jsbmb.2015.12.013 .
41	PUTZ M， PIPER T， THEVIS M. Identification of trenbolone metabolites using hydrogen isotope ratio mass spectrometry and liquid chromatography/high accuracy/high resolution mass spectrometry for doping control analysis[J]. Front Chem，2020，8：435. doi：10.3389/fchem.2020.00435 .
42	MATOS R R， DE SOUZA ANSELMO C， SARDELA V F， et al. Phase Ⅱ stanozolol metabolism study using the zebrafish water tank （ZWT） model[J]. J Pharm Biomed Anal，2021，195：113886. doi：10.1016/j.jpba.2020.113886 .
43	MURESAN A R， RAHAMAN K A， SON J， et al. Metabolites identification of anabolic steroid bolasterone in vitro and in rats by high resolution liquid chromatography mass spectrometry[J]. Drug Test Anal，2023，15（11/12）：1329-1343. doi：10.1002/dta.3447 .
44	CHOI T L S， WONG J K Y， KWOK W H， et al. Metabolic study of methylstenbolone in horses using liquid chromatography-high resolution mass spectrometry and gas chromatography-mass spectrometry[J]. J Chromatogr A，2018，1546：106-118. doi：10.1016/j.chroma.2018.02.041 .
45	MARTINEZ-BRITO D， DE LA TORRE X， COLAMONICI C， et al. 7-keto-DHEA　metabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field[J]. Drug Test Anal，2019，11（11/12）：1629-1643. doi：10.1002/dta.2734 .
46	FITZGERALD C C J， HEDMAN R， UDUWELA D R， et al. Profiling urinary sulfate metabolites with mass spectrometry[J]. Front Mol Biosci，2022，9：829511. doi：10.3389/fmolb.2022.829511 .
47	PIPER T， FUSSHÖLLER G， SCHÄNZER W， et al. Investigations on the in vivo metabolism of 5α- androst-2-en-17-one[J]. Rapid Commun Mass Spectrom，2022，36（17）：e9343. doi：10.1002/rcm.9343 .
48	WEI Y， SUN Y， JIA S， et al. Identification of endogenous carbonyl steroids in human serum by chemical derivatization， hydrogen/deuterium exchange mass spectrometry and the quantitative structure-retention relationship[J]. J Chromatogr B Analyt Technol Biomed Life Sci，2023，1226：123776. doi：10.1016/j.jchromb.2023.123776 .
49	SKRZYPEK G. Philip J. H. Dunn， Jim F. Carter （Eds.）： Good practice guide for isotope ratio mass spectrometry， 2nd ed[J]. Anal Bioanal Chem，2019，411（5）：965-966. doi：10.1007/s00216-018-1562-0 .

编号	目标物	样本	前处理方法	检测方法	LOD	文献
1	21种AAS及其酯（氯司替勃、孕三烯酮、四氢孕三烯酮等）	尿液	稀释注射法	LC-Orbitrap-HRMS	0.5~18 ng/mL	[13]
2	司坦唑醇	尿液	稀释注射法联合在线固相萃取	UPLC-Orbitrap-HRMS	75 pg/mL	[14]
3	11种AAS（前列他唑、依西美坦、美曲勃龙等）	尿液	液液萃取	LC-Orbitrap-HRMS	0.05~0.5 ng/mL	[15]
4	70种AAS及其酯（勃地酮、卡芦睾酮、达那唑等）	尿液	液液萃取	GC-Orbitrap-HRMS	0.1~1.25 ng/mL	[16]
5	8种AAS（睾酮、表睾酮、雄诺龙等）	血液	固相萃取	UPLC-Orbitrap-HRMS	0.006~7.904 ng/mL	[17]
6	7种AAS（普拉睾酮、美雄醇、雄烯二醇等）	尿液、头发	中空纤维溶剂-搅拌棒微萃取装置	GC-Orbitrap-HRMS	尿液<0.1 ng/mL，头发<0.1 ng/mL	[18]
7	睾酮、普拉睾酮、雄诺龙等	头发	固相萃取和液液萃取	UPLC-Orbitrap-HRMS	0.3~3.5 pg/mg	[19]
8	41种AAS及其酯（屈他雄酮丙酸酯、诺乙雄龙、宝丹酮醋酸酯等）	马毛	液液萃取	UPLC-Orbitrap-HRMS	除癸酸诺龙（15.7 pg/mg）、癸酸睾酮（15.7 pg/mg）和屈他雄酮丙酸酯（32.5 pg/mg）外，其余为0.2~10 pg/mg	[20]
9	司坦唑醇	体毛（头发、腋毛、腿毛等）	液液萃取	UPLC-Q-TOF-HRMS	2 pg/mg	[21]
10	勃地酮、美雄酮、美雄醇、司坦唑醇等	干血斑	液液萃取	LC-Orbitrap-HRMS	0.03~2.25 ng/mL	[22]
11	13种AAS（环戊丙酸睾酮、十一酸睾酮和异丁酸睾酮等）	干血斑	DBSA-TLX-HRMS系统	LC-Orbitrap-HRMS	0.2~0.5 ng/mL	[23]
12	4种睾酮酯（癸酸睾酮、异己酸睾酮、苯丙酸睾酮和丙酸睾酮）	干血斑	液液萃取	nanoLC-Orbitrap-HRMS	50~200 pg/mL	[24]
13	依诺波沙	指甲、头发	液液萃取	LC-Orbitrap-HRMS	均为0.5 pg/mg	[25]
14	司坦唑醇	猪血浆、猪精液	液液萃取	LC-Orbitrap-HRMS	猪血浆：0.02~0.40 ng/mL；猪精液：0.01~0.25 ng/mL	[26]

编号	目标物	样本	前处理方法	检测方法	LOD	文献
1	21种AAS及其酯（氯司替勃、孕三烯酮、四氢孕三烯酮等）	尿液	稀释注射法	LC-Orbitrap-HRMS	0.5~18 ng/mL	[13]
2	司坦唑醇	尿液	稀释注射法联合在线固相萃取	UPLC-Orbitrap-HRMS	75 pg/mL	[14]
3	11种AAS（前列他唑、依西美坦、美曲勃龙等）	尿液	液液萃取	LC-Orbitrap-HRMS	0.05~0.5 ng/mL	[15]
4	70种AAS及其酯（勃地酮、卡芦睾酮、达那唑等）	尿液	液液萃取	GC-Orbitrap-HRMS	0.1~1.25 ng/mL	[16]
5	8种AAS（睾酮、表睾酮、雄诺龙等）	血液	固相萃取	UPLC-Orbitrap-HRMS	0.006~7.904 ng/mL	[17]
6	7种AAS（普拉睾酮、美雄醇、雄烯二醇等）	尿液、头发	中空纤维溶剂-搅拌棒微萃取装置	GC-Orbitrap-HRMS	尿液<0.1 ng/mL，头发<0.1 ng/mL	[18]
7	睾酮、普拉睾酮、雄诺龙等	头发	固相萃取和液液萃取	UPLC-Orbitrap-HRMS	0.3~3.5 pg/mg	[19]
8	41种AAS及其酯（屈他雄酮丙酸酯、诺乙雄龙、宝丹酮醋酸酯等）	马毛	液液萃取	UPLC-Orbitrap-HRMS	除癸酸诺龙（15.7 pg/mg）、癸酸睾酮（15.7 pg/mg）和屈他雄酮丙酸酯（32.5 pg/mg）外，其余为0.2~10 pg/mg	[20]
9	司坦唑醇	体毛（头发、腋毛、腿毛等）	液液萃取	UPLC-Q-TOF-HRMS	2 pg/mg	[21]
10	勃地酮、美雄酮、美雄醇、司坦唑醇等	干血斑	液液萃取	LC-Orbitrap-HRMS	0.03~2.25 ng/mL	[22]
11	13种AAS（环戊丙酸睾酮、十一酸睾酮和异丁酸睾酮等）	干血斑	DBSA-TLX-HRMS系统	LC-Orbitrap-HRMS	0.2~0.5 ng/mL	[23]
12	4种睾酮酯（癸酸睾酮、异己酸睾酮、苯丙酸睾酮和丙酸睾酮）	干血斑	液液萃取	nanoLC-Orbitrap-HRMS	50~200 pg/mL	[24]
13	依诺波沙	指甲、头发	液液萃取	LC-Orbitrap-HRMS	均为0.5 pg/mg	[25]
14	司坦唑醇	猪血浆、猪精液	液液萃取	LC-Orbitrap-HRMS	猪血浆：0.02~0.40 ng/mL；猪精液：0.01~0.25 ng/mL	[26]

编号	目标物	样本类型	检测方法	检测结果	文献
1	19-去甲睾酮	尿液	IRMS-GC-Q-TOF-HRMS	Ⅰ相代谢物10个：M1~M10；Ⅱ相代谢物11个：M11~M21	[40]
2	群勃龙	尿液	IRMS-LC-Q-TOF-HRMS	20种代谢物，包括葡萄糖醛酸酯、硫酸酯和潜在的半胱氨酸偶联物	[41]
3	司坦唑醇	斑马鱼	LC-Orbitrap-HRMS	4种葡萄糖醛酸酯代谢物和4种硫酸酯代谢物	[42]
4	勃拉睾酮	大鼠肝微粒体、血液	LC-Orbitrap-HRMS	Ⅰ相代谢物17个：M1~M17；Ⅱ相代谢物1个：M18	[43]
5	甲基司腾勃龙	马肝微粒体、尿液、血液	UPLC-Orbitrap-HRMS	体外肝微粒体：6种代谢物；体内尿液和血液：共14种代谢物	[44]
6	7-羰基-普拉睾酮	尿液	IRMS-GC-Q-TOF-HRMS	10种Ⅰ相代谢物以不同形式与葡萄糖醛酸酯和硫酸酯结合排出体外	[45]

编号	目标物	样本类型	检测方法	检测结果	文献
1	19-去甲睾酮	尿液	IRMS-GC-Q-TOF-HRMS	Ⅰ相代谢物10个：M1~M10；Ⅱ相代谢物11个：M11~M21	[40]
2	群勃龙	尿液	IRMS-LC-Q-TOF-HRMS	20种代谢物，包括葡萄糖醛酸酯、硫酸酯和潜在的半胱氨酸偶联物	[41]
3	司坦唑醇	斑马鱼	LC-Orbitrap-HRMS	4种葡萄糖醛酸酯代谢物和4种硫酸酯代谢物	[42]
4	勃拉睾酮	大鼠肝微粒体、血液	LC-Orbitrap-HRMS	Ⅰ相代谢物17个：M1~M17；Ⅱ相代谢物1个：M18	[43]
5	甲基司腾勃龙	马肝微粒体、尿液、血液	UPLC-Orbitrap-HRMS	体外肝微粒体：6种代谢物；体内尿液和血液：共14种代谢物	[44]
6	7-羰基-普拉睾酮	尿液	IRMS-GC-Q-TOF-HRMS	10种Ⅰ相代谢物以不同形式与葡萄糖醛酸酯和硫酸酯结合排出体外	[45]

[1]	Jiao-jiao JI, Xin WANG, Jia-man LIN, Duo-qi XU, Hui YAN, Min SHEN. Research Progress on the Application of MALDI-MSI in Hair Analysis [J]. Journal of Forensic Medicine, 2024, 40(6): 542-549.
[2]	Si-yang HE, Qian-ya DENG, Shui-qing ZHENG, Chun-fang NI, Wen-juan SUN, Fang-qi CAO, Chen LIANG, Fei-jun GONG. Identification of a Novel Synthetic Cathinone CMMP [J]. Journal of Forensic Medicine, 2024, 40(6): 550-556.
[3]	Xian-yu FAN, Xue-yan ZHU, Xin WANG, Ping XIANG, Jun-bo ZHAO. High Resolution Mass Spectrometry Fragmentation Rules of Etomidate and Its Structural Analogues [J]. Journal of Forensic Medicine, 2024, 40(6): 557-563.
[4]	Zhu-tao GUO, Qian-ya DENG, Si-yang HE, Shui-qing ZHENG, Rong WANG, Wen-juan SUN, Chen LIANG, Chun-fang NI. Rapid Screening of 60 Types of Natural Toxins in Whole Blood by UPLC-Q/Orbitrap HRMS [J]. Journal of Forensic Medicine, 2024, 40(6): 564-568.
[5]	Ying ZHANG, Wen-fang ZHANG, Duo-qi XU, Shi-yang QIN, Shi-yun YANG, Jing QIAO. Analysis of In Vitro Mirtazapine Metabolites in Human Liver Microsomes by LC-HRMS [J]. Journal of Forensic Medicine, 2024, 40(6): 569-574.
[6]	Guo-qing GAO, Shuo YANG, Li-ying ZHOU, Shi-bei DU, Yan SHI. In Vivo Analysis of New Psychoactive Substances： Nitazenes [J]. Journal of Forensic Medicine, 2024, 40(6): 597-607.
[7]	Hong-xia HAO, Jie-min CHEN, Xiao-ying YU, Meng WANG, Zhi-lu ZHOU, Yan-liang SHENG, Wen-tao XIA. Estimation of Visual Acuity after Recovery from Different Degrees of Ocular Trauma Using Pattern Visual Evoked Potential [J]. Journal of Forensic Medicine, 2024, 40(5): 447-453.
[8]	Zhi YAN, Xun-ming JI, Xiao HE, Xiao-jing ZHANG, Lei WAN, Hong ZHANG, Mei TIAN, Bin CONG. Progress and Application Prospects of Forensic Molecular Imaging Technology in Living Individual Examination [J]. Journal of Forensic Medicine, 2024, 40(5): 476-483.
[9]	Jing LIU, Zheng WANG, Yi-ping HOU, Lin-chuan LIAO. The Impact of STR Mutations on Kinship Identification [J]. Journal of Forensic Medicine, 2024, 40(5): 484-491.
[10]	Qi-rui HAN, Wen-ji ZHANG, Hao-yang LI, Ying-chao LUO. Current Status and Prospects of Bloodstain Age Estimation Technology [J]. Journal of Forensic Medicine, 2024, 40(5): 468-475.
[11]	Tian-fu HE, Huan-hui ZHU, Yuan-yuan TIAN, Yin-shuang JIN, Xian-wen LIN, Song-cai WANG. Detection of Etomidate and Etomidate Acid in Urine Using HPLC-MS/MS Method [J]. Journal of Forensic Medicine, 2024, 40(5): 454-460.
[12]	Hao-jie QIN, Yuan-yuan LIU, En-hao FU, Ya-wen LIU, Zhi-ling TIAN, He-wen DONG, Tai-ang LIU, Dong-hua ZOU, Yi-bin CHENG, Ning-guo LIU. Intelligent Recognition and Segmentation of Blunt Craniocerebral Injury CT Images Based on DeepLabV3+ Model [J]. Journal of Forensic Medicine, 2024, 40(5): 419-429.
[13]	Jing-chen GE, Min SHANG, Ming-yang YAO, Ming-fei WEI, Jun-zhan SHI, Ze-wei YAO, Jia-yin SHI, Fan LI. Application of MSCT Image Post-Processing Techniques in the Identification of Rib Fracture Malunion [J]. Journal of Forensic Medicine, 2024, 40(4): 324-329.
[14]	Yu-jiao WU, Yue-qin ZHOU, Yi-wen SHEN, Jie-qing JIANG. Analysis of 39 Forensic Clinical Sex Identification Cases after Sex Reassignment Surgery [J]. Journal of Forensic Medicine, 2024, 40(4): 365-371.
[15]	Ming-hui JIN, Ya LI, Shao-hua YI. Research Progress on the Application of Human Body Surface Microbiome to Forensic Individual Identification [J]. Journal of Forensic Medicine, 2024, 40(4): 379-386.